Latest stories on ARGX
Argenx price target lowered to $1,232 from $1,301 at Citi
The Fly38 · neutralanalyst
TD Cowen reiterates argenx stock Buy rating on Vyvgart strength
Investing.com Analyst Ratings63 · neutralanalyst
Argenx price target raised to $1,190 from $1,140 at Morgan Stanley
The Fly63 · neutralanalyst
Argenx price target lowered to $1,120 from $1,185 at Guggenheim
The Fly38 · neutralanalyst
argenx: 3 Key Takeaways for Long-Term Investors
The Motley Fool63 · neutralgeneral
Argenx price target raised to $861 from $823 at Baird
The Fly63 · neutralanalyst
Argenx price target lowered to $1,336 from $1,356 at Wells Fargo
The Fly42 · neutralanalyst
argenx (ARGX) Q3 2026 Earnings Call Transcript
The Motley Fool74 · bullishearnings
Argenx Earnings Call: VYVGART Surge Fuels 2027 Pivot
TipRanks63 · neutralearnings
Baird raises argenx stock price target to $861 on Vyvgart sales
Investing.com Analyst Ratings64 · neutralanalyst
Argenx outlines 2026 OpEx at ~$4B as it plans up to 5 U.S. launches in 2027
Seeking Alpha58 · neutralearnings
Jefferies reiterates argenx stock Buy rating after Q3 beat
Investing.com Analyst Ratings63 · neutralanalyst
Stifel cuts argenx stock price target on mixed quarter results
Investing.com Analyst Ratings34 · bearishanalyst
argenx posts $1.7B Q3 2026 VYVGART net sales and sets up December MMN data catalyst for empasiprubart
October 22, 2026
MarketChameleon74 · bullishearnings
Argenx Slumps On Mixed Third Quarter, Surprise Vyvgart Testing Plans
Investors.com34 · bearishearnings
Why is argenx stock sliding today?
Investing.com Markets38 · neutralgeneral
argenx Q3 revenue and profit rises
Seeking Alpha74 · bullishearnings
argenx Reports Third Quarter 2026 Financial Results and Provides Business Update
Business Insider74 · bullishearnings
argenx Reports Third Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire74 · bullishearnings
Citi adds ‘upside 90-day catalyst watch’ on Argenx
The Fly63 · neutralanalyst
argenx spotlights 15.4-point TIS advantage in ALKIVIA as ACR Convergence 2026 late-breaker
October 20, 2026
MarketChameleon64 · neutralproduct/pr
Argenx price target lowered to $1,025 from $1,100 at RBC Capital
The Fly38 · neutralanalyst
RBC Capital cuts argenx stock price target on Sjögren’s setback
Investing.com Analyst Ratings34 · bearishanalyst
argenx to Present Phase 3 ALKIVIA Results in Autoimmune Myositis as a Late-Breaking Oral Presentation at ACR Convergence 2026
GlobeNewswire63 · neutralproduct/pr
argenx to Present Phase 3 ALKIVIA Results in Autoimmune Myositis as a Late-Breaking Oral Presentation at ACR Convergence 2026
Business Insider63 · neutralproduct/pr